What's in Emergent BioSolutions's pipeline?

Emergent BioSolutions has 19 drugs in our index: 6 marketed, 0 filed, 0 in Phase 3, 6 in Phase 2, 7 in Phase 1.

Which companies overlap with Emergent BioSolutions's portfolio?

Top competitors by shared drug class: GlaxoSmithKline, Universitaire Ziekenhuizen KU Leuven.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/emergent-biosolutions.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

Emergent BioSolutions — Portfolio Competitive Intelligence Brief

Emergent BioSolutions pipeline: 6 marketed, 0 filed, 0 Phase 3, 6 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

6 marketed 0 filed 0 Phase 3 6 Phase 2 7 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
AVA	AVA	marketed	Inactivated bacterial vaccine	Bacillus anthracis protective antigen (PA) and lethal factor	Immunology / Infectious Disease
ACAM2000	ACAM2000	marketed			Other
CYFENDUS	CYFENDUS	marketed			Infectious Disease
Vaccination with ACAM2000	Vaccination with ACAM2000	marketed
Blood sample collection	Blood sample collection	marketed
Sample Collection	Sample Collection	marketed

Therapeutic area mix

Immunology · 1
Immunology / Infectious Disease · 1
Infectious Disease · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

GlaxoSmithKline · 1 shared drug class
Universitaire Ziekenhuizen KU Leuven · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Emergent BioSolutions:

Cite this brief

Drug Landscape (2026). Emergent BioSolutions — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/emergent-biosolutions. Accessed 2026-05-14.